A study to evaluate the efficacy of Eclipta prostrata (L.) L. in the treatment of atopic dermatitis in childre

Phase 2

• Conditions: Atopic dermatits; C16.320.850

• Registration Number: RBR-2fqcbrx
• Lead Sponsor: Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo - USP

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-12-16
• Last Update Posted: 29 May 2023
• Study Completion: 2025-12-01

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Children and adolescents between 2 and 18 years old; clinical diagnosis of atopic dermatitis, according to the Hanifin and Rajka criteria

Exclusion Criteria

Diagnosis or presence of acute or chronic cutaneous diseases, not suggestive of atopic dermatitis, that may interfere with the study results; use of corticosteroids, systemic immunosuppressants or immunobiologicals for at least 30 days before or during participation in the study; allergy or serious adverse events attributable to the administration of the investigational product; non-adherence to treatment (ie, not using the investigational product regularly, as prescribed) for at least one continuous month; failure to attend more than 50% of the evaluations (clinical and/or laboratory) that will be carried out during the study

Study & Design

• Study Type: Intervention
• Study Design: Not specified